Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Raiden B. Hasegawa & Dylan S. Small. (2022) Estimating Malaria Vaccine Efficacy in the Absence of a Gold Standard Case Definition: Mendelian Factorial Design. Journal of the American Statistical Association 117:539, pages 1466-1481.
Read now
Read now
Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan & Navin Khanna. (2019) Next generation designer virus-like particle vaccines for dengue. Expert Review of Vaccines 18:2, pages 105-117.
Read now
Read now
Pascale Vandoolaeghe & Lode Schuerman. (2016) The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Expert Review of Vaccines 15:12, pages 1481-1493.
Read now
Read now
Geert Leroux-Roels, Isabel Leroux-Roels, Frédéric Clement, Opokua Ofori-Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W Ripley Ballou & Joe Cohen. (2014) Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics 10:8, pages 2211-2219.
Read now
Read now
Anton Beletskii, Ashley Galloway, Shyam Rele, Michele Stone & Frank Malinoski. (2014) Engineered PRINT® nanoparticles for controlled delivery of antigens and immunostimulants. Human Vaccines & Immunotherapeutics 10:7, pages 1908-1913.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Serena Tschan, Peter G Kremsner & Benjamin Mordmüller. (2012) Emerging drugs for malaria. Expert Opinion on Emerging Drugs 17:3, pages 319-333.
Read now
Read now
Mark J Geels, Egeruan B Imoukhuede, Nathalie Imbault, Harry van Schooten, Terry McWade, Marita Troye-Blomberg, Roland Dobbelaer, Alister G Craig & Odile Leroy. (2011) European Vaccine Initiative: lessons from developing malaria vaccines. Expert Review of Vaccines 10:12, pages 1697-1708.
Read now
Read now
Eleanor Barnes & Andrew J Pollard. (2011) Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10:5, pages 555-557.
Read now
Read now
Articles from other publishers (65)
Miusi Shi & Kevin J. McHugh. (2023) Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems. Advanced Drug Delivery Reviews 199, pages 114904.
Crossref
Crossref
Ekta Mukhopadhyay, Florian Brod, Philip Angell‐Manning, Nicola Green, Richard D. Tarrant, Frank J. Detmers, Emma J. Bolam, Ioana N. Baleanu, Mark Hobson, Gary Whale, Susan J. Morris, Rebecca Ashfield, Sarah C. Gilbert, Jing Jin, Simon J. Draper, Sarah P. Moyle, Eleanor L. Berrie & Adrian V. S. Hill. (2022)
Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in
Pichia pastoris
under cGMP conditions
. Biotechnology and Bioengineering 119:10, pages 2784-2793.
Crossref
Crossref
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Jack N Hutter, Paul M. Robben, Christine Lee, Melinda Hamer, James E. Moon, Kristen Merino, Lei Zhu, Heather Galli, Xiaofei Quinn, Dallas R. Brown, Elizabeth Duncan, Jessica Bolton, Xiaoyan Zou, Evelina Angov, David E. Lanar, Mangala Rao, Gary R. Matyas, Zoltan Beck, Elke Bergmann-Leitner, Lorraine A. Soisson, Norman C. Waters, Viseth Ngauy, Jason Regules & Sheetij Dutta. (2022) First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults. Vaccine 40:40, pages 5781-5790.
Crossref
Crossref
Cosette G. Schneider, Julien Fey, Xiaoyan Zou, Vince Gerbasi, Tatyana Savransky, Carl Batt, Elke Bergmann-Leitner & Evelina Angov. (2022) Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. Vaccine 40:31, pages 4270-4280.
Crossref
Crossref
Ana Rafaela Teixeira, Begoña Pérez-Cabezas, David M. Costa, Mónica Sá, Sylvain Golba, Hélèna Sefiane-Djemaoune, Joana Ribeiro, Izumi Kaneko, Shiroh Iwanaga, Masao Yuda, Moriya Tsuji, Silvia Beatriz Boscardin, Rogerio Amino, Anabela Cordeiro-da-Silva & Joana Tavares. (2022) Immunization with CSP and a RIG-I Agonist is Effective in Inducing a Functional and Protective Humoral Response Against Plasmodium. Frontiers in Immunology 13.
Crossref
Crossref
Ian W. Hamley. (2022) Peptides for Vaccine Development. ACS Applied Bio Materials 5:3, pages 905-944.
Crossref
Crossref
Jishnu Das, Jonathan K. Fallon, Timothy C. Yu, Ashlin Michell, Todd J. Suscovich, Caitlyn Linde, Harini Natarajan, Joshua Weiner, Margherita Coccia, Scott Gregory, Margaret E. Ackerman, Elke Bergmann-Leitner, Laura Fontana, Sheetij Dutta, Douglas A. Lauffenburger, Erik Jongert, Ulrike Wille-Reece & Galit Alter. (2021) Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. Med 2:11, pages 1269-1286.e9.
Crossref
Crossref
Srinivasa Reddy Bonam, Laurent Rénia, Ganesh Tadepalli, Jagadeesh Bayry & Halmuthur Mahabalarao Sampath Kumar. (2021) Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants. Vaccines 9:10, pages 1072.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Navid D. Djadid & Akram A. Mehrizi. (2021) A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development. International Journal for Parasitology 51:9, pages 699-717.
Crossref
Crossref
Dongmei Cun, Chengqian Zhang, Hriday Bera & Mingshi Yang. (2021) Particle engineering principles and technologies for pharmaceutical biologics. Advanced Drug Delivery Reviews 174, pages 140-167.
Crossref
Crossref
Mehreen S Datoo, Magloire H Natama, Athanase Somé, Ousmane Traoré, Toussaint Rouamba, Duncan Bellamy, Prisca Yameogo, Daniel Valia, Moubarak Tegneri, Florence Ouedraogo, Rachidatou Soma, Seydou Sawadogo, Faizatou Sorgho, Karim Derra, Eli Rouamba, Benedict Orindi, Fernando Ramos Lopez, Amy Flaxman, Federica Cappuccini, Reshma Kailath, Sean Elias, Ekta Mukhopadhyay, Andres Noe, Matthew Cairns, Alison Lawrie, Rachel Roberts, Innocent Valéa, Hermann Sorgho, Nicola Williams, Gregory Glenn, Louis Fries, Jenny Reimer, Katie J Ewer, Umesh Shaligram, Adrian V S Hill & Halidou Tinto. (2021) Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. The Lancet 397:10287, pages 1809-1818.
Crossref
Crossref
Rebeca T. Stiepel, Cole J. Batty, Christopher A. MacRaild, Raymond S. Norton, Eric Bachelder & Kristy M. Ainslie. (2021) Merozoite surface protein 2 adsorbed onto acetalated dextran microparticles for malaria vaccination. International Journal of Pharmaceutics 593, pages 120168.
Crossref
Crossref
Peter D. Kwong, Brandon J. DeKosky & Jeffrey B. Ulmer. (2020) Antibody-guided structure-based vaccines. Seminars in Immunology 50, pages 101428.
Crossref
Crossref
Guoyu Yang, Sheng Chen & Jianxiang Zhang. (2019) Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases. Frontiers in Pharmacology 10.
Crossref
Crossref
Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski, Istvan Toth, Danielle I. Stanisic & Michael F. Good. (2019) Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines. Frontiers in Immunology 10.
Crossref
Crossref
Mona O. Mohsen, Lisha Zha, Gustavo Cabral-Miranda & Martin F. Bachmann. (2017) Major findings and recent advances in virus–like particle (VLP)-based vaccines. Seminars in Immunology 34, pages 123-132.
Crossref
Crossref
Kristian E. Swearingen, Scott E. Lindner, Erika L. Flannery, Ashley M. Vaughan, Robert D. Morrison, Rapatbhorn Patrapuvich, Cristian Koepfli, Ivo Muller, Aaron Jex, Robert L. Moritz, Stefan H. I. Kappe, Jetsumon Sattabongkot & Sebastian A. Mikolajczak. (2017) Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites. PLOS Neglected Tropical Diseases 11:7, pages e0005791.
Crossref
Crossref
Akane Urakami, Atsuko Sakurai, Momoko Ishikawa, Moh Lan Yap, Yevel Flores-Garcia, Yasunari Haseda, Taiki Aoshi, Fidel P. Zavala, Michael G. Rossmann, Sachiko Kuno, Ryuji Ueno & Wataru Akahata. (2017) Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus. Clinical and Vaccine Immunology 24:7.
Crossref
Crossref
Katharine A. Collins, Rebecca Snaith, Matthew G. Cottingham, Sarah C. Gilbert & Adrian V. S. Hill. (2017) Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. Scientific Reports 7:1.
Crossref
Crossref
Diego A. Espinosa, Dennis Christensen, Christian Muñoz, Sanjay Singh, Emily Locke, Peter Andersen & Fidel Zavala. (2017) Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection. npj Vaccines 2:1.
Crossref
Crossref
James G. KublinSebastian A. MikolajczakBrandon K. SackMatt E. FishbaugherAnnette SeilieLisa SheltonTracie VonGoedertMelike FiratSara MageeEmma FritzenWill BetzHeather S. KainDorender A. DankwaRyan W. J. SteelAshley M. VaughanD. Noah SatherSean C. MurphyStefan H. I. Kappe. (2017)
Complete attenuation of genetically engineered
Plasmodium falciparum
sporozoites in human subjects
. Science Translational Medicine 9:371.
Crossref
Crossref
Katya Galactionova, Fabrizio Tediosi, Flavia Camponovo, Thomas A. Smith, Peter W. Gething & Melissa A. Penny. (2017) Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa. Vaccine 35:1, pages 53-60.
Crossref
Crossref
Michael Waisberg, Peter D. Crompton, Louis H. Miller & Susan K. Pierce. 2016. Advances in Malaria Research. Advances in Malaria Research
495
519
.
John Clemens & Vasee Moorthy. (2016) Implementation of RTS,S/AS01 Malaria Vaccine — The Need for Further Evidence. New England Journal of Medicine 374:26, pages 2596-2597.
Crossref
Crossref
Kevin A McCarthy, Edward A Wenger, Grace H Huynh & Philip A Eckhoff. (2015) Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine. Malaria Journal 14:1.
Crossref
Crossref
Yimin Wu, David L. Narum, Sylvain Fleury, Gary Jennings & Anjali Yadava. (2015) Particle-based platforms for malaria vaccines. Vaccine 33:52, pages 7518-7524.
Crossref
Crossref
Fouzia Farooq & Elke S. Bergmann-Leitner. (2015) Immune Escape Mechanisms are Plasmodium ’ s Secret Weapons Foiling the Success of Potent and Persistently Efficacious Malaria Vaccines. Clinical Immunology 161:2, pages 136-143.
Crossref
Crossref
Michiko Hyakumura, Renae Walsh, Morten Thaysen-Andersen, Natalie J. Kingston, Mylinh La, Louis Lu, George Lovrecz, Nicolle H. Packer, Stephen Locarnini & Hans J. Netter. (2015) Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. Journal of Virology 89:22, pages 11312-11322.
Crossref
Crossref
Nyamekye Obeng-Adjei, Silvia Portugal, Tuan M. Tran, Takele B. Yazew, Jeff Skinner, Shanping Li, Aarti Jain, Philip L. Felgner, Ogobara K. Doumbo, Kassoum Kayentao, Aissata Ongoiba, Boubacar Traore & Peter D. Crompton. (2015) Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Children. Cell Reports 13:2, pages 425-439.
Crossref
Crossref
Nishant K. Jain, Neha Sahni, Ozan S. Kumru, Sangeeta B. Joshi, David B. Volkin & C. Russell Middaugh. (2015) Formulation and stabilization of recombinant protein based virus-like particle vaccines. Advanced Drug Delivery Reviews 93, pages 42-55.
Crossref
Crossref
Susanna Dunachie, Adrian V.S. Hill & Helen A. Fletcher. (2015) Profiling the host response to malaria vaccination and malaria challenge. Vaccine 33:40, pages 5316-5320.
Crossref
Crossref
Christian F. Ockenhouse, Jason Regules, Donna Tosh, Jessica Cowden, April Kathcart, James Cummings, Kristopher Paolino, James Moon, Jack Komisar, Edwin Kamau, Thomas Oliver, Austin Chhoeu, Jitta Murphy, Kirsten Lyke, Matthew Laurens, Ashley Birkett, Cynthia Lee, Rich Weltzin, Ulrike Wille-Reece, Martha Sedegah, Jenny Hendriks, Isabella Versteege, Maria Grazia Pau, Jerold Sadoff, Yannick Vanloubbeeck, Marc Lievens, Dirk Heerwegh, Philippe Moris, Yolanda Guerra Mendoza, Erik Jongert, Joe Cohen, Gerald Voss, W. Ripley Ballou & Johan Vekemans. (2015) Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults. PLOS ONE 10:7, pages e0131571.
Crossref
Crossref
Joe J. Campo, John J. Aponte, Jeff Skinner, Rie Nakajima, Douglas M. Molina, Li Liang, Jahit Sacarlal, Pedro L. Alonso, Peter D. Crompton, Philip L. Felgner & Carlota Dobaño. (2015) RTS,S Vaccination Is Associated With Serologic Evidence of Decreased Exposure to Plasmodium falciparum Liver- and Blood-Stage Parasites*. Molecular & Cellular Proteomics 14:3, pages 519-531.
Crossref
Crossref
Nishi Mody, Rajeev Sharma, Udita Agrawal & Suresh P Vyas. (2015) Nanocarriers: a versatile approach for mucosal vaccine delivery. Therapeutic Delivery 6:2, pages 231-245.
Crossref
Crossref
Peter Michael Moyle. (2015) Progress in Vaccine Development. Current Protocols in Microbiology 36:1.
Crossref
Crossref
Lars Hviid & Anja T.R. Jensen. 2015.
51
84
.
Anke Harupa, Brandon K. Sack, Viswanathan Lakshmanan, Nadia Arang, Alyse N. Douglass, Brian G. Oliver, Andrew B. Stuart, D. Noah Sather, Scott E. Lindner, Kevin Hybiske, Motomi Torii & Stefan H. I. Kappe. (2014) SSP3 Is a Novel Plasmodium yoelii Sporozoite Surface Protein with a Role in Gliding Motility. Infection and Immunity 82:11, pages 4643-4653.
Crossref
Crossref
Rich Umeh, Stephen Oguche, Tagbo Oguonu, Simon Pitmang, Elvis Shu, Jude-Tony Onyia, Comfort A. Daniyam, David Shwe, Abdullahi Ahmad, Erik Jongert, Grégory Catteau, Marc Lievens, Opokua Ofori-Anyinam & Amanda Leach. (2014) Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial. Vaccine 32:48, pages 6556-6562.
Crossref
Crossref
Luis A. Brito & Derek T. O'Hagan. (2014) Designing and building the next generation of improved vaccine adjuvants. Journal of Controlled Release 190, pages 563-579.
Crossref
Crossref
M. Spring, M. Polhemus & C. Ockenhouse. (2014) Controlled Human Malaria Infection. Journal of Infectious Diseases 209:suppl 2, pages S40-S45.
Crossref
Crossref
Stefan HE Kaufmann, M Juliana McElrath, David JM Lewis & Giuseppe Del Giudice. (2014) Challenges and responses in human vaccine development. Current Opinion in Immunology 28, pages 18-26.
Crossref
Crossref
Nora Céspedes, Eliécer Jiménez, Mary Lopez-Perez, Kelly Rubiano, Ingrid Felger, Pedro Alonso, Myriam Arévalo-Herrera, Giampietro Corradin & Sócrates Herrera. (2014) Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct. Vaccine 32:26, pages 3179-3186.
Crossref
Crossref
Tom Egwang. 2014. Malaria Vaccine Development: Over 40 Years of Trials and Tribulations. Malaria Vaccine Development: Over 40 Years of Trials and Tribulations
106
121
.
Daria Jacob, Claude Ruffie, Myriam Dubois, Chantal Combredet, Rogerio Amino, Pauline Formaglio, Olivier Gorgette, Gérard Pehau-Arnaudet, Charline Guery, Odile Puijalon, Jean-Christophe Barale, Robert Ménard, Frédéric Tangy & Monica Sala. (2014) Whole Pichia pastoris Yeast Expressing Measles Virus Nucleoprotein as a Production and Delivery System to Multimerize Plasmodium Antigens. PLoS ONE 9:1, pages e86658.
Crossref
Crossref
Fernando Cobo. 2014. Imported Infectious Diseases. Imported Infectious Diseases
61
90
.
K. Sony Reddy, Alok K. Pandey, Hina Singh, Tajali Sahar, Amlabu Emmanuel, Chetan E. Chitnis, Virander S. Chauhan & Deepak Gaur. (2014) Bacterially Expressed Full-Length Recombinant Plasmodium falciparum RH5 Protein Binds Erythrocytes and Elicits Potent Strain-Transcending Parasite-Neutralizing Antibodies. Infection and Immunity 82:1, pages 152-164.
Crossref
Crossref
Aya C Taki & Peter M Smooker. (2014) The malaria war. Microbiology Australia 35:3, pages 153.
Crossref
Crossref
Elke S. Bergmann-Leitner, Qigui Li, Diana Caridha, Michael T. O’Neil, Christian F. Ockenhouse, Mark Hickman & Evelina Angov. (2014) Protective immune mechanisms against pre-erythrocytic forms of Plasmodium berghei depend on the target antigen. Trials in Vaccinology 3, pages 6-10.
Crossref
Crossref
Michele Spring, Jittawadee Murphy, Robin Nielsen, Megan Dowler, Jason W. Bennett, Stasya Zarling, Jack Williams, Patricia de la Vega, Lisa Ware, Jack Komisar, Mark Polhemus, Thomas L. Richie, Judy Epstein, Cindy Tamminga, Ilin Chuang, Nancy Richie, Michael O’Neil, D. Gray Heppner, Julie Healer, Matthew O’Neill, Hannah Smithers, Olivia C. Finney, Sebastian A. Mikolajczak, Ruobing Wang, Alan Cowman, Christian Ockenhouse, Urszula Krzych & Stefan H.I. Kappe. (2013) First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine 31:43, pages 4975-4983.
Crossref
Crossref
Silvia Portugal, Susan K. Pierce & Peter D. Crompton. (2013) Young Lives Lost as B Cells Falter: What We Are Learning About Antibody Responses in Malaria. The Journal of Immunology 190:7, pages 3039-3046.
Crossref
Crossref
Jessica M. Moffat, Wan-Shoo Cheong, José A. Villadangos, Justine D. Mintern & Hans J. Netter. (2013) Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells. Vaccine 31:18, pages 2310-2316.
Crossref
Crossref
Thomas J. Powell, Jie Tang, Mary E. DeRome, Robert A. Mitchell, Andrea Jacobs, Yanhong Deng, Naveen Palath, Edwin Cardenas, James G. Boyd & Elizabeth Nardin. (2013) Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses. Vaccine 31:15, pages 1898-1904.
Crossref
Crossref
M. Aubert, J. Beytout, P. Callamand, J. Cheymol, B. Combadière, A. Dahlab, F. Denis, B. Dodet, M.-A. Dommergues, A. Gagneur, J. Gaillat, G. Gavazzi, C. Gras-le-Guen, H. Haas, I. Hau-Rainsard, D. Malvy, J.-V. de Monléon, G. Picherot, D. Pinquier, J.-L. Pretet, C. Pulcini, C. Rabaud, F. Regnier, O. Rogeaux, C. Savagner, B. Soubeyrand, M. Valdiguié & C. Weil-Olivier. (2013) Actualités en matière de recherche vaccinale. Compte-rendu de la 15e conférence annuelle sur la recherche vaccinale organisée par la National Foundation for Infectious Diseases. Archives de Pédiatrie 20:4, pages 449-458.
Crossref
Crossref
Kathrin Kastenmüller, Diego A. Espinosa, Lauren Trager, Cristina Stoyanov, Andres M. Salazar, Santosh Pokalwar, Sanjay Singh, Sheetij Dutta, Christian F. Ockenhouse, Fidel Zavala & Robert A. Seder. (2013)
Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4
+
T Cell Immunity and Protection in Mice
. Infection and Immunity 81:3, pages 789-800.
Crossref
Crossref
Eleanor M Riley & V Ann Stewart. (2013) Immune mechanisms in malaria: new insights in vaccine development. Nature Medicine 19:2, pages 168-178.
Crossref
Crossref
Wing-Chui Chong, Rusliza Basir & Yam Mun Fei. (2013) Eradication of malaria through genetic engineering: the current situation. Asian Pacific Journal of Tropical Medicine 6:2, pages 85-94.
Crossref
Crossref
D. Gray Heppner. (2013) The malaria vaccine – Status quo 2013. Travel Medicine and Infectious Disease 11:1, pages 2-7.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
Frederic Clement, Vincent Dewar, Eva Van Braeckel, Isabelle Desombere, Marianne Dewerchin, Christine Swysen, Marie-Ange Demoitié, Erik Jongert, Joe Cohen, Geert Leroux-Roels & Pierre Cambron. (2012) Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum. Malaria Journal 11:1.
Crossref
Crossref
Anjali Yadava, Saule Nurmukhambetova, Alexander V. Pichugin & Joanne M. Lumsden. (2012) Cross-Species Immunity Following Immunization With a Circumsporozoite Protein–Based Vaccine for Malaria. The Journal of Infectious Diseases 205:9, pages 1456-1463.
Crossref
Crossref
Douglas S. Watson, Aaron N. Endsley & Leaf Huang. (2012) Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:13, pages 2256-2272.
Crossref
Crossref
Huaiyu Zhou, Juan Min, Qunli Zhao, Qinmin Gu, Hua Cong, Ying Li & Shenyi He. (2012) Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 30:10, pages 1800-1806.
Crossref
Crossref
Sarah C. Gilbert. (2011) T‐cell‐inducing vaccines – what’s the future. Immunology 135:1, pages 19-26.
Crossref
Crossref
Fabien Rebeaud & Martin Bachmann. 2012. Innovation in Vaccinology. Innovation in Vaccinology
87
122
.